- 米国企業
- Adaptive Biotechnologies Corp
Adaptive Biotechnologies CorpADPT
時価総額
$5.2億
PER
2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | |
Sequencing Revenue | 44 | 41 | 79 | - |
Development Revenue | 42 | 57 | 75 | - |
Revenue | 85 | 98 | 154 | 185 |
Cost of revenue | 22 | 23 | 49 | 58 |
Research and development | 71 | 116 | 142 | 142 |
Sales and marketing | 38 | 61 | 95 | 96 |
General and administrative | 30 | 50 | 75 | 89 |
Amortization of intangible assets | 2 | 2 | 2 | 2 |
Total operating expenses | 163 | 251 | 363 | 385 |
Loss from operations | -78 | -153 | -209 | -200 |
Interest and Other Income | 10 | 7 | 2 | 4 |
Interest expense | - | - | - | 4 |
Net loss | -69 | -146 | -207 | -200 |
Add: Net loss attributable to noncontrolling interest | - | - | -0 | -0 |
Net loss attributable to Adaptive Biotechnologies Corporation | -69 | -146 | -207 | -200 |
Earnings Per Share, Basic | - | - | - | -1.4 |
Earnings Per Share, Diluted | - | - | - | -1.4 |